Epiomic Epidemiology Report: Rett Syndrome Forecast In 23 Major Markets 2018-2028 - ResearchAndMarkets.com

DUBLIN--()--The "Epiomic Epidemiology Series: Rett Syndrome Forecast In 23 Major Markets 2018-2028" report has been added to ResearchAndMarkets.com's offering.

Rett syndrome (RTT) is a rare neurodevelopmental disorder characterised by loss of acquired skills after a period of apparently normal development. It is divided into typical, atypical and variant forms, most of which affect girls. It used to be considered as one of the autism spectrum disorders, but when its aetiology was determined to be an X-linked (rarely autosomal) single-gene mutation, it was removed from that group and is now considered as a separate pathological entity.

This report provides the current prevalent female population for Rett syndrome across 23 Major Markets (USA, Canada, France, Germany, Italy, Spain, UK, Poland, Netherlands, Norway, Sweden, Switzerland, Estonia, Russia, Turkey, Japan, China, South Korea, India, Australia, Brazil, Mexico, Argentina) split by 5-year age cohort. In addition to the current prevalence, the report provides an overview of the risk factors, diagnosis and prognosis of the disease, along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the publisher's analysis team, several features of Rett syndrome patients, as well as the main comorbidities of the disease have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities of Rett syndrome include:

  • Gastrointestinal problems (gastro-oesophageal reflux, constipation)
  • Nutritional problems (poor weight gain)
  • Musculoskeletal problems (scoliosis, kyphosis, spasticity, joint deformities)
  • Long QT syndrome
  • Seizures

Key Topics Covered:

  1. Introduction
  2. Cause Of The Disease
  3. Risk Factors & Prevention
  4. Diagnosis Of The Disease
  5. Variation By Geography/Ethnicity
  6. Disease Prognosis & Clinical Course
  7. Key Comorbid Conditions / Features Associated With The Disease
  8. Methodology For Quantification Of Patient Numbers
  9. Top-Line Prevalence For Rett Syndrome
  10. Features Of Autism Spectrum Disorder Patients
  11. Comorbidities Of Rett Syndrome Patients
  12. Abbreviations Used In The Report
  13. Other Black Swan Services & Solutions
  14. Reports & Publications
  15. Online Epidemiology Databases
  16. Online Pharmaceutical Pricing Database
  17. References
  18. Appendix

For more information about this report visit https://www.researchandmarkets.com/research/547ckh/epiomic?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Central Nervous System Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Central Nervous System Drugs